Hi, what are you looking for?
BioLight also announced that a new private investor participated in the private placement with the same terms in the amount of $350, 000.
Eucalyptus will focus on investing and helping late stage Israeli companies
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
Mylan's filing on executive compensation reveals much higher pay than at Teva.
Mylan, itself the subject of a hostile takeover bid from Teva, is raising its offer for Perrigo for the second time. Mylan N.V. has...
In the 26 Apr 2015 edition of Israel’s good news, the highlights include: · An Israeli hospital has opened the world’s largest pressurized...
Both Perrigo and Teva are down on the Tel Aviv Stock Exchange following the Independence Day break. After US-Israeli pharmaceuticals company Perrigo (PRGO) rejected...
The rejection assists Teva's $41 billion bid for Mylan, which is contingent on the Perrigo deal not going ahead.
In the 12th Apr 2015 week’s edition of Israel’s good news, the highlights include: Two major Israeli scientific breakthroughs may lead to new cancer...
The body’s immune system can easily recognize its own cells